These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32891071)

  • 21. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The overall computer/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study.
    Meng G; Liu F; Fang L; Li C; Zhang Q; Liu L; Wu H; Du H; Shi H; Xia Y; Guo X; Liu X; Bao X; Su Q; Gu Y; Yu F; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Guo Q; Chen X; Song K; Wang G; Huang G; Niu K
    Ann Med; 2016 Nov; 48(7):568-576. PubMed ID: 27649339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.
    Weinstein G; Davis-Plourde K; Himali JJ; Zelber-Sagi S; Beiser AS; Seshadri S
    Liver Int; 2019 Sep; 39(9):1713-1721. PubMed ID: 31155826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of non-alcoholic fatty liver disease].
    Anty R; Gual P
    Presse Med; 2019 Dec; 48(12):1468-1483. PubMed ID: 31767252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health].
    Vallet-Pichard A; Parlati L; Pol S
    Presse Med; 2019 Dec; 48(12):1459-1467. PubMed ID: 31757728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study.
    Pitisuttithum P; Chan WK; Piyachaturawat P; Imajo K; Nakajima A; Seki Y; Kasama K; Kakizaki S; Fan JG; Song MJ; Yoon SK; Dan YY; Lesmana L; Ho KY; Goh KL; Wong VWS; Treeprasertsuk S
    BMC Gastroenterol; 2020 Apr; 20(1):88. PubMed ID: 32252638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing liver fibrosis in patients with NAFLD and the road ahead.
    Nobili V; Miele L; Alisi A
    Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1081-1083. PubMed ID: 28994314
    [No Abstract]   [Full Text] [Related]  

  • 30. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
    Federico A; Zulli C; de Sio I; Del Prete A; Dallio M; Masarone M; Loguercio C
    World J Gastroenterol; 2014 Dec; 20(45):16841-57. PubMed ID: 25492998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease.
    Maurice J; Manousou P
    Clin Med (Lond); 2018 Jun; 18(3):245-250. PubMed ID: 29858436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
    Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial Issues in Pediatric Nonalcoholic Fatty Liver Disease.
    Karaivazoglou K; Kalogeropoulou M; Assimakopoulos S; Triantos C
    Psychosomatics; 2019; 60(1):10-17. PubMed ID: 30318268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
    Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progress in the Management of NAFLD/NASH].
    Aizawa Y
    Rinsho Byori; 2016 Jul; 64(7):797-805. PubMed ID: 30695468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    Le MH; Devaki P; Ha NB; Jun DW; Te HS; Cheung RC; Nguyen MH
    PLoS One; 2017; 12(3):e0173499. PubMed ID: 28346543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic Fatty Liver Disease in Children.
    Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
    Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research advances in diagnosis of non-alcoholic fatty liver disease].
    Wang JH; Yu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):115-118. PubMed ID: 28297797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.